Cytosorbents Corporation (CTSO) vs IRIDEX Corporation (IRIX)

A side-by-side comparison of Cytosorbents Corporation and IRIDEX Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CTSO vs IRIX

growth of $100 · dividends reinvested · last 10y
CTSO -96.7% (-28.9%/yr)IRIX -95.2% (-26.2%/yr)IRIX compounded faster over this window
050100150200250Start $10020182020202220242026$3$5
CTSO IRIX

CTSO vs IRIX: by the numbers

  • •CTSO is the larger company ($13M vs $12M market cap).
  • •Both run net losses; IRIX's is the smaller (-6.88% vs -48.94% net margin).
  • •Both shrank revenue over the past five years; IRIX's decline was smaller (-0.57% vs -3.17% CAGR).

Metrics side by side

Valuation

MetricCTSOIRIX
P/S ratio0.340.23

Profitability

MetricCTSOIRIX
Gross margin71.61%36.23%
Operating margin-33.37%-5.39%
Net margin-48.94%-6.88%
ROEN/A-97.47%
ROIC-43.31%-19.53%

Growth (annualized)

MetricCTSOIRIX
Revenue CAGR (5Y)-3.17%-0.57%
Total return CAGR (5Y)-52.26%-38.13%

Frequently asked

Which has grown faster, CTSO or IRIX?
Neither grew: over the past five years both shrank revenue, with IRIX's decline the smaller — CTSO at a -3.17% CAGR versus IRIX at -0.57%.
How have CTSO and IRIX total returns compared?
Over the past 10 years, CTSO delivered -28.72% and IRIX delivered -26.14% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.